https://www.marketscreener.com/quote/stock/PURPLE-BIOTECH-LTD-24978833/news/Purple-Biotech-Presents-Data-of-its-Phase-1-Head-Neck-Cancer-of-NT219-in-combination-with-Cetuxima-46037753/?utm_source=telegram&utm_medium=social&utm_campaign=share